October 31, 2011
Richard Pops, Chief Executive Officer of Alkermes, explains how the company has established itself as a global, Irish-based firm.
 |
September 2, 2011
By:Gregory Skalicky
Big Pharma has increasingly turned to strategic outsourcing models to realize their own enterprise-wide strategic goals. Small- and medium-sized companies need to follow suit.
|
June 5, 2011
Is it a coincidence that the ABPI has netted a whole shoal of conduct contraveners in the first month its amended Code of Practice became operational?
|
June 1, 2011
Hungary?s failure to advance EU legislation on information to patients is not the country?s fault, says Reflector.
|
May 1, 2011
By:Reflector
The EU is largely powerless when it comes to policies over pricing and reimbursement
|
April 1, 2011
By:Reflector
EU leadership on pharma policy leaves many wondering of the right man is at the helm
|
April 1, 2011
By:Philippa Montgomerie
Philippa Montgomerie outlines the implications of the Court of Justice of the European Union's recent patent litigation forum shopping.
|
February 25, 2011
By:Doug Kitson
Changes in the field of oncology in the last twenty years have led to complex networks between physicians. Doug Kitson reports on how Cegedim's Physician Connect Oncology aims to optimize these.
|
November 4, 2010
By:Erik Greb
November 6, 2010.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
